Monthly Archives: May 2012

Three Tendring beaches keep their Blue Flag status

Posted on by

Three Tendring beaches keep their Blue Flag status

12:40pm Wednesday 16th May 2012 in News By James Dwan

THREE beaches on Tendrings Sunshine Coast have retained their prestigious Blue Flags.

The awards, organised by Keep Britain Tidy, are made for offering visitors top-quality facilities, litter-free beaches and a safe environment.

Tendring Council said the accolades for Brightlingsea, Dovercourt and Clactons Martello Bay beaches offer a boost for the districts tourist trade before the summer season starts.

Tendrings beaches also held on to their six Quality Coast Awards for Martello Bay and West Beach, Clacton, Frinton Beach, Harwich Beach, Albion Beach, Walton, and the Naze, at Walton.

Stephen Mayzes, cabinet member for tourism, said: We already set very high standards for our holiday beaches, which are a vital part of the tourist offer in the district. We work hard to make sure our golden sands will attract people year after year and ensure they are also an important amenity where our residents can relax and improve their well-being. He added: While we know we have some of the best beaches and will strive to keep them that way it is great, and a real bonus to have this recognised by others .

Mr Mayzes said guidelines for water quality will be changing in 2015, which will make it more difficult for beaches to retain the honours.

He added: We are already holding talks with Anglian Water, who are responsible for water quality along the coastline, about this and what can be done in the future.

The Blue Flag scheme, launched by the Foundation for Environmental Education in 1987, recognises high standards in a number of criteria covering environmental education and information, water quality, environmental management, safety and services.

See original here:

Three Tendring beaches keep their Blue Flag status

Smoking ban plan for beaches

Posted on by

Angela Burden, of Grange, with Alexander, 4 and Jamie, 8 months, at Henley Beach. Mrs Burden supports a proposal to ban smoking at the beach. Picture: Ian Roddie Source: AdelaideNow

WESTERN beaches could have "no smoking" sections under a proposal to be considered by Charles Sturt and Port-Enfield councils.

Charles Sturt Council will develop a policy on smoking, following concerns raised by some elected members about people lighting up in public outdoor areas, such as playgrounds and public open spaces, the Weekly Times Messenger reports.

Mayor Gary Johanson was also keen to apply for a ban on beaches in Port-Enfield, and said the council would consult the community before any changes were made.

The bans would be the first of their kind in SA, although there are already smoking restrictions in place at beaches in most Australian states.

>>For the full story, and to leave a comment, visit the Weekly Times Messenger website.

Go here to see the original:

Smoking ban plan for beaches

Beaches, the most favoured holiday destinations: Survey

Posted on by

Mumbai, May 16:

Beaches seem to be the most favoured holiday destinations by travellers.

A survey conducted by online travel agency Expedia highlighted that 80 per cent of Indian travellers are already planning to go for a beach vacation in the next 12 months.

About 53 per cent Indians went to a domestic beach on their most recent trip while 47 per cent opted for an international beach, the survey said.

The survey reveals that as opposed to the general perception of high price sensitivity, the most important criteria for Indians to decide on a beach vacation is food and beverage reputation as well as the novelty of the destination, said Mr Manmeet Ahluwalia, Marketing Head, Expedia India.

This survey was conducted online by Harris Interactive on behalf of Expedia.com among 8,599 adults across 21 countries, including India.

Indians place new experiences over relaxation, with over 60 per cent travelling for the experience of another culture alongside being on the beach.

Amongst different criteria for beach preference, 76 per cent of Indians prefer to go to a beach with tourist attractions near the beach or surrounding area, followed by water and sand quality, weather predictability and secluded beach environment.

When it comes to travelling, Indian women look for a secluded beach environment, the survey said.

Mumbai took the highest share of domestic vacations at 60 per cent while Delhi led the international destination vacation segment at 47 per cent.

Read this article:

Beaches, the most favoured holiday destinations: Survey

The long reach of the Centaur’s dark heart | Bad Astronomy

Posted on by

Every now again I get surprised by a photo, showing me something I didnt know about. And I love it even more when that surprise is from an object I thought I knew!

So check out this incredible image of the nearby galaxy Centaurus A, a nearby galaxy harboring a whole slew of surprises:

[Click to galactinate, or get the 4000 x 4000 pixel version, or, if you're feeling frisky, cram this onto your hard drive: an image that's 8500 x 8400 pixels and 29 Mb in size! And trust me: you want to.]

Isnt that stunning? This picture was taken by the MPG/ESO 2.2 meter telescope in Chile, and once you get over its beauty youll realize this galaxy is, frankly, seriously messed up.

Cen A is about 12 million light years away and has roughly the same mass as our Milky Way, containing a few hundred billion stars. The underlying glow of those stars is what makes that round background fuzz in the image, and takes on the familiar elliptical shape of many such galaxies. [Note: All the individual stars you see here are in our on galaxy, since we're inside the Milky Way looking out to Cen A. Also, the little circles next to bright stars are reflections inside the camera itself, and aren't real.]

But check out that wide swath of dark stuff across the middle! That blocks the light from stars behind it, so its a cold certainty thats a dust lane: a thick, flat disk of complex molecules commonly seen in galaxies. But its commonly seen in spiral galaxies like ours, not elliptical ones like Cen A. So somethings weird right off the bat. And note how the ends of the disk seem bent in opposite directions; on the right its bent down, and on the left its bent up.

Most likely, this is because Cen A ate another galaxy. Literally: a galaxy collided with it in the recent past well, like in the past few dozen million years and that galaxy was probably more like our own, rich with dust. As it was absorbed, the dust was stripped from it and settled into that disk. The warping at the ends is a gravitational effect, most likely a distortion from the collision itself. We see it in other galaxies that have nearby companions.

When you observe Cen A using a radio telescope it gets weirder: two huge jets of material are being shot out of the core. The image here shows those jets (click to embiggen). Cen A is a very strong emitter of radio waves; in fact thats why its called Cen A: the brightest radio source in the constellation of Centaurus.

The source of those jets is a gigantic black hole in the core of the galaxy. All big galaxies have one, but Cen As is 55 million times the mass of the Sun nearly 14 times the mass of the black hole in the center of our own galaxy! So its a bruiser. Unlike our Milky Ways black hole, the one in Cen A is actively feeding on material. A huge amount of gas is falling into it. As it does, it forms a flattened disk which gets very, very hot. Millions of degrees hot. Swirling magnetic fields and other forces focus the material into those twins beams which scream out from the disk and create the radio waves. We call these active galaxies.

Read the original here:

The long reach of the Centaur’s dark heart | Bad Astronomy

UAE's aerospace dream blooms in the desert

Posted on by

By Tim Hepher

AL AIN, United Arab Emirates (Reuters) - Ross Bradley welcomes a delegation of aerospace suppliers in from the blistering heat of the Arabian desert and cools them down with some refreshingly candid advice.

"You are too expensive. Please take this message back. We will not put up with prices we are paying today. Unaffordable."

The welcome speech may not always be soothing to the ear but industry visitors keep flocking to the remote oasis town of Al Ain in the United Arab Emirates to see one of the world's newest and best-equipped aerospace factories.

They are drawn by the dramatic rise of an ambitious and increasingly powerful player in the fast-growing aerospace industry, which is investing to make jets cheaper to fly.

Flanked by dunes on an ancient Frankincense route from Yemen to Mesopotamia, the factory is designed to help make lightweight carbon jets that will open up the trade lanes of the future.

It sprang from the desert in record time to spearhead Abu Dhabi's ambitions to diversify its oil-dependent economy and produce high-tech jobs for the company's mainly female local workforce.

"We put the first spade into the sand in September 2009 and when we started you couldn't get here in a vehicle; you had to drive by 4x4 and then walk," says Bradley, chief executive of Strata, the aerostructures business funded by Abu Dhabi.

The project is part of efforts by the UAE's main exporting emirate to boost the non-oil economy to 56 percent of GDP by 2020 and 64 percent in 2030, up from 41 percent in 2005-07.

It is trying to do what many have long considered impossible - to challenge the biggest parts industry players from Asia to the United States in a short time and at even lower cost, while developing a previously unproven workforce.

Read the rest here:

UAE's aerospace dream blooms in the desert

XCOR Aerospace Announces Lynx Suborbital Flight Winner

Posted on by

MOJAVE, Calif., May 16, 2012 /PRNewswire/ -- XCOR Aerospace today announced the grand prize winner of a trip aboard the Lynx Mark I suborbital launch vehicle. XCOR Chief Operating Officer Andrew Nelson made the announcement at the Spacecraft Technology Expo (STE) in Los Angeles, CA.

(Photo: http://photos.prnewswire.com/prnh/20120516/LA08278)

"About two months ago, we were at an event called the Next-Generation Suborbital Researchers Conference, where together with the Southwest Research Institute (SwRI) we gave away a suborbital flight," said XCOR Chief Operating Officer Andrew Nelson. "We had a winner, and we had a backup.Unfortunately our main winner was unable to accept the prize.Our backup winner, Jennifer Brisco, is now the official recipient of the suborbital flight."

Jennifer, who hails from the San Francisco Bay Area was flown in to the Spacecraft Technology Expo in Los Angeles to receive the prize. She did not know that she had been selected until presented with the award at the Expo.

"It's been my lifetime goal to take a suborbital flight," said Jennifer."This is an absolute dream ... I am in shock right now, I am speechless."

Jennifer, who is a space enthusiast, will be eligible to fly on the Lynx mark I as a suborbital researcher after passing a medical exam and completing a three day training program that includes altitude and G-force exposure.

"XCOR continues to bring down the costs and barriers associated with commercial human spaceflight," remarked Andrew."Reusable Launch Vehicles such as Lynx will usher in a whole new era of accessibility to space by offering routine, affordable and safe trips outside the atmosphere. We look forward to being on the vanguard of this revolution in affordable access to the cosmos."

XCOR Aerospace is a California corporation located in Mojave, California. The company is in the business of developing and producing safe, reliable and reusable rocket powered vehicles, propulsion systems, advanced non-flammable composites and other enabling technologies like rocket piston pumps that enable full reusability. XCOR is working with aerospace prime contractors and government customers on major propulsion systems, and concurrently building the Lynx, a piloted, two-seat, fully reusable, liquid rocket powered vehicle that takes off and lands horizontally. The Lynx-family of vehicles serves three primary missions depending on their specific type including: research & scientific missions, private spaceflight, and micro satellite launch (only on the Lynx Mark III). The Lynx production models (designated Lynx Mark II) are designed to be robust, multi-mission (research / scientific or private spaceflight) commercial vehicles capable of flying to 100+ km in altitude up to four times per day and are being offered globally on a wet lease basis. (www.xcor.com).

Visit link:

XCOR Aerospace Announces Lynx Suborbital Flight Winner

Ball Aerospace Submits Solar Electric Propulsion Concept to NASA

Posted on by

BOULDER, Colo., May 16, 2012 /PRNewswire/ --Ball Aerospace & Technologies Corp. has submitted its mission concept study to NASA for demonstrating solar electric propulsion (SEP) technologies in space.

(Photo: http://photos.prnewswire.com/prnh/20120516/LA08133)

Ball Aerospace was one of five companies awarded up to $600,000 by NASA in September 2011,to formulate a mission concept to demonstrate the solar electric propulsion technologies, capabilities, and infrastructure required for sustainable and affordable human presence in space. NASA will use the studies to plan and implement a future flight demonstration mission to test and validate those science technologies and capabilities.

"Ball Aerospace recognizes the mission enabling aspect of solar electric propulsion and our customer needs for SEP solutions," said Cary Ludtke, vice president of Ball's Civil and Operational Space business unit. "We believe we're the right-sized company with the right capabilities to take this space technology to the next level."

The current study focused on developing concepts that will be using technology at NASA Technology Readiness Level (TRL) 5 or greater. Ball's mission concept supports NASA's goal to elevate SEP technologies in order to create more efficient and powerful solar-powered flight systems. Ball Aerospace worked with several companies to create an implementable solar electronic technology demonstration mission for NASA including: ATK Space Systems, Busek Co. Inc., Deployable Space Systems, Gray Research Inc., and the Southwest Research Institute.

Ball Aerospace & Technologies Corp. supports critical missions for national agencies such as the Department of Defense, NASA, NOAA and other U.S. government and commercial entities. The company develops and manufactures spacecraft, advanced instruments and sensors, components, data exploitation systems and RF solutions for strategic, tactical and scientific applications. For more information visit http://www.ballaerospace.com.

Ball Corporation (BLL) is a supplier of high quality packaging for beverage, food and household products customers, and of aerospace and other technologies and services, primarily for the U.S. government. Ball Corporation and its subsidiaries employ more than 14,500 people worldwide and reported 2011 sales of more than $8.6 billion. For the latest Ball news and for other company information, please visit http://www.ball.com.

Forward-Looking Statements

This release contains "forward-looking" statements concerning future events and financial performance. Words such as "expects," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those expressed or implied. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Key risks and uncertainties are summarized in filings with the Securities and Exchange Commission, including Exhibit 99.2 in our Form 10-K, which are available on our website and at http://www.sec.gov. Factors that might affect our packaging segments include fluctuation in product demand and preferences; availability and cost of raw materials; competitive packaging availability, pricing and substitution; changes in climate and weather; crop yields; competitive activity; failure to achieve anticipated productivity improvements or production cost reductions; mandatory deposit or other restrictive packaging laws; changes in major customer or supplier contracts or loss of a major customer or supplier; political instability and sanctions; and changes in foreign exchange rates or tax rates. Factors that might affect our aerospace segment include: funding, authorization, availability and returns of government and commercial contracts; and delays, extensions and technical uncertainties affecting segment contracts. Factors that might affect the company as a whole include those listed plus: accounting changes; changes in senior management; the recent global recession and its effects on liquidity, credit risk, asset values and the economy; successful or unsuccessful acquisitions; regulatory action or laws including tax, environmental, health and workplace safety, including U.S. FDA and other actions affecting products filled in our containers, or chemicals or substances used in raw materials or in the manufacturing process; governmental investigations; technological developments and innovations; goodwill impairment; antitrust, patent and other litigation; strikes; labor cost changes; rates of return projected and earned on assets of the company's defined benefit retirement plans; pension changes; uncertainties surrounding the U.S. government budget and debt limit; reduced cash flow; interest rates affecting our debt; and changes to unaudited results due to statutory audits or other effects.

Read the original post:

Ball Aerospace Submits Solar Electric Propulsion Concept to NASA

Global Aerospace and Defence Industry

Posted on by

NEW YORK, May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Aerospace and Defence Industry

http://www.reportlinker.com/p0459131/Global-Aerospace-and-Defence-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Aerospace

This report analyzes the worldwide markets for Aerospace and Defense Industry in US$ Million by the following Major Industrial Sectors: Aircraft Products & Services (Airframe, Aircraft Engine, Aircraft Components, Commercial Avionics, Military Avionics, In-flight Entertainment, & MRO), Missiles (Air-to-Air, Air-to-Surface, Air Defense, Surface-to-Surface, Antiship, Antitank, Bombs (Guided), Intelligent Munitions, & Others), Modeling, Simulation and Training (CBT & E-Learning, Military Training & Simulation, Commercial & Military Visual Simulation, & Commercial & Military Flight Simulation), C4ISR & Related (Unmanned Aerial Vehicle, Electronic Warfare, Mine Countermeasures, Naval Radar and Sonar, Chemical & Biological Agent Detectors, Infrared Imaging Systems and Components, Military Ground Communications, Land-Based Surveillance Radar, & Others), Space Equipment (Launch Vehicles, Communications Satellites, & Earth Observation Satellites), and GPS (Geotechnologies) (Commercial Satellite Imaging, Commercial Aerial Imaging, GIS Software, Commercial SAR Data, and Commercial SAR Software). Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America. The report profiles 438 companies including many key and niche players such as Arianespace SA, ATR, B/E Aerospace, Inc., BAE Systems Plc, Ball Aerospace & Technologies Corporation, Bell Helicopter Textron, Inc., Bombardier, Inc. Cessna Aircraft Company, CFM International Inc., DAHER-SOCATA, EADS N.V, Airbus S.A.S, Eurocopter, Embraer S.A, Finmeccanica S.p.A., AgustaWestland S.p.A, GE Aviation, Goodrich Corporation, Gulfstream Aerospace Corporation, Hawker Beechcraft Corporation, Honeywell International, Inc., Ilyushin Aviation Complex JSC, IRKUT Corporation, Israel Aerospace Industries Ltd., Kaman Corporation, Lockheed Martin Corporation, Northrop Grumman Corporation, Pratt & Whitney, Raytheon Company, Rolls-Royce Plc, RUAG AG, Sikorsky Aircraft Corporation, Snecma SA, Thales Group, The Boeing Company, and Turbomeca SA. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

See the article here:

Global Aerospace and Defence Industry

The Ventyx Wesley Research Institute Tissue Bank Joins the BioServe Network

Posted on by

BELTSVILLE, MD--(Marketwire -05/16/12)- BioServe today announced that the Ventyx Wesley Research Institute Tissue Bank, the largest state-of-the-art bio-repository of human tissue and blood in Queensland, Australia, has joined BioServe's network of affiliated bio-repositories. As part of the BioServe Network, the Ventyx Wesley Research Institute Tissue Bank will make available its high volume of oncology tissue and blood samples to industry and academic researchers worldwide. The collaborative partnership between BioServe and the Wesley Research Institute was facilitated by Bio-Link Australia Pty. Ltd., a life sciences commercialisation company.

The Ventyx Wesley Research Institute Tissue Bank joins the growing BioServe Network that includes Fox Chase Cancer Center, University of Massachusetts Medical School, the Windber Research Institute, and Maine Medical Center. The Network, along with BioServe's Global BioRepository, creates the largest commercial-ready specimen repository in the world with over 2 million samples in most major diseases. Such specimens hold the data driving genetic and biomarker discovery and validation for effective patient stratification, drug discovery and development of new diagnostics.

The Ventyx Wesley Research Institute Tissue Bank was founded in 2007 and is a purpose-built research facility established to provide a diverse collection of ethically obtained tissue specimens for biomedical research. The Tissue Bank operates at the Wesley Research Institute, which is located on the Wesley Hospital campus in Auchenflower, Brisbane. It collects and stores tissue samples, blood and related clinical data from consenting patients at The Wesley Hospital and makes these specimens and clinical data available to ethically approved medical researchers. The Tissue Bank adheres to the international standards set down in Good Clinical Practice and Good Laboratory Practice guidelines.

"We are pleased that the Ventyx Wesley Research Institute Tissue Bank will make its high quality tissue samples available through the BioServe Network. By tapping this unique and comprehensive sample resource, researchers can quickly obtain most any type of human biological sample in most any disease," said Rama Modali, President of BioServe.

"Becoming part of the BioServe Network will enable us to reach a greater proportion of the scientific research community, putting our samples into the hands of researchers developing new therapies and diagnostics," said Dr. Greg Hafner, Chief Operations Officer of the Wesley Research Institute.

About BioServe BioServe provides a comprehensive 'biomaterial to validated data' genomics services platform, helping researchers gain the pre-clinical data for breakthroughs in drug discovery, molecular diagnostics and pharmacogenomics. Utilizing BioServe's genomics services platform, researchers can identify genetic markers, validate drug targets and correlate clinical data with molecular data to accelerate the development of new and safer drugs. BioServe's services extend from nucleic acids processing, DNA synthesis, high throughput genotyping, genome wide-scans and gene expression analyses to ready-made large epidemiologically sound case-control studies of inflammatory disorders, endocrine disorders, cardiovascular disease, diabetes, hypertension, obesity and many cancers. BioServe's Global BioRepository provides researchers with a library of 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data from 120,000 consented and anonymized patients from four continents.

For more information please visit http://www.bioserve.com or call 301-470-3362.

About Wesley Research InstituteThe Wesley Research Institute is an independent, not-for-profit medical research organisation that conducts research focusing on improving patient care and quality of life. Its clinical and applied research aims to discover, test and refine new techniques for better diagnosis and treatment of illness and disease that work towards its motto of 'making a difference today.' Wesley Research Institute provides a range of scientific services across three main areas -- Investigative Research, Clinical Trials and Tissue Banking.

For more information please visit http://www.wesleyresearch.org.au or email enquiries@wesleyresearch.com.au.

About Bio-Link AustraliaBio-Link Australia Pty. Ltd., with offices in Melbourne and Sydney, is a life sciences commercialisation company offering professional business development services to facilitate commercial partnerships in the biopharmaceutical and diagnostic industries. Bio-Link's clients include leading biotechnology companies and medical research institutes located in Australia and around the world. For more information please visit http://www.bio-link.com.

See the rest here:
The Ventyx Wesley Research Institute Tissue Bank Joins the BioServe Network

Study Finds Head Impacts in Contact Sports May Reduce Learning in College Athletes

Posted on by

Newswise MINNEAPOLIS A new study suggests that head impacts experienced during contact sports such as football and hockey may worsen some college athletes ability to acquire new information. The research is published in the May 16, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

The study involved college athletes at three Division I schools and compared 214 athletes in contact sports to 45 athletes in non-contact sports such as track, crew and Nordic skiing at the beginning and at the end of their seasons. The contact sport athletes wore special helmets that recorded the acceleration speed and other data at the time of any head impact.

The contact sport athletes experienced an average of 469 head impacts during the season. Athletes were not included in the study if they were diagnosed with a concussion during the season.

All of the athletes took tests of thinking and memory skills before and after the season. A total of 45 contact sport athletes and 55 non-contact sport athletes from one of the schools also took an additional set of tests of concentration, working memory and other skills.

The good news is that overall there were few differences in the test results between the athletes in contact sports and the athletes in non-contact sports, said study author Thomas W. McAllister, MD, of The Geisel School of Medicine at Dartmouth in Lebanon, N.H. But we did find that a higher percentage of the contact sport athletes had lower scores than would have been predicted after the season on a measure of new learning than the non-contact sport athletes.

A total of 22 percent of the contact sport athletes performed worse than expected on the test of new learning, compared to four percent of the non-contact sport athletes.

McAllister noted that the study did not find differences in test results between the two groups of athletes at the beginning of the season, suggesting that the cumulative head impacts that contact athletes had incurred over many previous seasons did not result in reduced thinking and memory skills in the overall group.

These results are somewhat reassuring, given the recent heightened concern about the potential negative effects of these sports, he said. Nevertheless, the findings do suggest that repetitive head impacts may have a negative effect on some athletes.

McAllister said its possible that some people may be genetically more sensitive to head impacts.

The study was supported by the National Institutes of Health and the National Operating Committee on Standards for Athletic Equipment.

Read the original post:
Study Finds Head Impacts in Contact Sports May Reduce Learning in College Athletes

United Kingdom Neurology Devices Market Outlook to 2018 – Interventional Neurology, Neurological Diagnostic Equipment …

Posted on by

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0862102/United-Kingdom-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the six market categories.- Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devicesmarket. - Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Accuray Incorporated, DePuy, Inc., Stryker Corporation, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the United Kingdom Neurology Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.1 Table of Contents1 Table of Contents 21.1 List of Tables 81.2 List of Figures 102 Introduction 132.1 What is This Report About? 133 Neurology Devices In United Kingdom 143.1 Neurology Devices, Market Segmentation 143.2 Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 153.3 Neurology Devices Market, United Kingdom, Revenue Mix ($m), 2011 173.4 Neurology Devices Market, United Kingdom, Category Contribution (%), 2011 183.5 Neurology Devices, United Kingdom, Company Share (2010-2011) 244 CSF Management In United Kingdom 264.1 CSF Management, Market Segmentation 264.2 CSF Management Market, United Kingdom, Revenue Mix ($m), 2011 274.3 CSF Management Market, United Kingdom, Segment Contribution (%), 2011 284.4 CSF Management Overall Revenue, (2004-2018) 294.5 CSF Management Overall Volume (2004-2018) 334.6 CSF Management Average Price (2004-2018) 354.7 CSF Management Distribution Share (2010-2011) 354.8 CSF Management, United Kingdom, Company Share (2010-2011) 365 Interventional Neurology In United Kingdom 385.1 Interventional Neurology, Market.Segmentation 385.2 Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2011 395.3 Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2011 405.4 Interventional Neurology Overall Revenue, (2004-2018) 415.4.1 Embolic Systems Revenue (2004-2018) 455.4.2 Navigational Systems Revenue (2004-2018) 495.5 Interventional Neurology Overall Volume (2004-2018) 535.5.1 Embolic Systems Volume (2004-2018) 575.5.2 Navigational Systems Volume (2004-2018) 595.6 Interventional Neurology Average Price (2004-2018) 615.7 Interventional Neurology Distribution Share (2010-2011) 625.8 Interventional Neurology, United Kingdom, Company Share (2010-2011) 636 Neurological Diagnostic Equipment In United Kingdom 656.1 Neurological Diagnostic Equipment, Market.Segmentation 656.2 Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2011 666.3 Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2011 676.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018) 686.5 Neurological Diagnostic Equipment Overall Volume (2004-2018) 726.6 Neurological Diagnostic Equipment Average Price (2004-2018) 766.7 Neurological Diagnostic Equipment Distribution Share (2010-2011) 776.8 Neurological Diagnostic Equipment, United Kingdom, Company Share (2010-2011) 787 Neurostimulation Devices In United Kingdom 807.1 Neurostimulation Devices, Market Segmentation 807.2 Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2011 817.3 Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2011 827.4 Neurostimulation Devices Overall Revenue, (2004-2018) 837.5 Neurostimulation Devices Overall Volume (2004-2018) 877.6 Neurostimulation Devices Average Price (2004-2018) 917.7 Neurostimulation Devices Distribution Share (2010-2011) 927.8 Neurostimulation Devices, United Kingdom, Company Share (2010-2011) 938 Neurosurgical Products In United Kingdom 948.1 Neurosurgical Products, Market Segmentation 948.2 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2011 958.3 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2011 968.4 Neurosurgical Products Overall Revenue, (2004-2018) 978.5 Neurosurgical Products Overall Volume (2004-2018) 1018.6 Neurosurgical Products Average Price (2004-2018) 1038.7 Neurosurgical Products Distribution Share (2010-2011) 1038.8 Neurosurgical Products, United Kingdom, Company Share (2010-2011) 1049 Radiosurgery In United Kingdom 1059.1 Radiosurgery, Market Segmentation 1059.2 Radiosurgery Market, United Kingdom, Revenue Mix ($m), 2011 1069.3 Radiosurgery Market, United Kingdom, Segment Contribution (%), 2011 1079.4 Radiosurgery Overall Revenue, (2004-2011) 1089.5 Radiosurgery Overall Volume (2004-2011) 1109.6 Radiosurgery Average Price (2004-2011) 1119.7 Radiosurgery Distribution Share (2010-2011) 1119.8 Radiosurgery, United Kingdom, Company Share (2010-2011) 11210 Overview of Key Companies in United Kingdom Neurology Devices Market 11310.1 Medtronic, Inc. 11310.1.1 Company Overview 11310.1.2 Share in the United Kingdom Neurology Devices Market 11310.2 St. Jude Medical, Inc. 11410.2.1 Company Overview 11410.2.2 Share in the United Kingdom Neurology Devices Market 11410.3 Accuray Incorporated 11510.3.1 Company Overview 11510.3.2 Share in the United Kingdom Neurology Devices Market 11510.4 DePuy, Inc. 11610.4.1 Company Overview 11610.4.2 Share in the United Kingdom Neurology Devices Market 11610.5 Stryker Corporation 11710.5.1 Company Overview 11710.5.2 Share in the United Kingdom Neurology Devices Market 11710.6 B. Braun Melsungen AG 11810.6.1 Company Overview 11810.6.2 Share in the United Kingdom Neurology Devices Market 11810.7 Boston Scientific Corporation 11910.7.1 Company Overview 11910.8 Cyberonics, Inc. 11910.8.1 Company Overview 11910.9 Terumo Corporation 12010.9.1 Company Overview 12010.10 Integra LifeSciences Holdings Corporation 12010.10.1 Company Overview 12010.11 Cadwell Laboratories, Inc. 12010.11.1 Company Overview 12010.12 Natus Medical Incorporated 12110.12.1 Company Overview 12110.13 Micromed S.p.A 12110.13.1 Company Overview 12110.14 Christoph Miethke GmbH & Co. KG 12110.14.1 Company Overview 12110.15 CareFusion Corporation 12210.15.1 Company Overview 12210.16 Nihon Kohden Corporation 12210.16.1 Company Overview 12210.17 KARL STORZ GmbH & Co. KG 12310.17.1 Company Overview 12310.18 Sophysa S.A. 12310.18.1 Company Overview 12310.19 Covidien plc 12310.19.1 Company Overview 12310.20 Elekta AB 12410.20.1 Company Overview 12411 Neurology Devices Market Pipeline Products 12512 Financial Deals Landscape 13112.1 Partnerships 13112.1.1 GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 13113 Recent Developments 13213.1 Government and Public Interest 13213.1.1 Apr 23, 2012: New Technique May Help Severely Damaged Nerves Regrow And Restore Function: University of Sheffield 13213.1.2 Jan 10, 2012: Fusion Plasma Research Helps Neurologists To Hear Above The Noise 13314 Appendix 13514.1 Definitions of Markets Covered in the Report 13614.1.1 Neurology Devices 13614.2 Research Methodology 14014.3 Secondary Research 14014.4 Primary Research 14114.5 Models 14114.6 Forecasts 14214.7 Expert Panels 14214.8 GlobalData Consulting 14214.9 Currency Conversion 14314.10 Contact Us 14314.11 Disclaimer 143

List of Tables

Table 1: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 15Table 2: Neurology Devices Market, United Kingdom, Category Contribution (%), 2011 17Table 3: Neurology Devices, United Kingdom, Cross-Category Analysis, 2004-2018 18Table 4: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20Table 5: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22Table 6: Neurology Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 24Table 7: CSF Management Market, United Kingdom, Segment Contribution (%), 2011 27Table 8: CSF Management, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 29Table 9: CSF Management, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 31Table 10: CSF Management, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 32Table 11: CSF Management, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 33Table 12: CSF Management, United Kingdom, Average Price ($), Historic, 2004-2011 34Table 13: CSF Management, United Kingdom, Average Price ($), Forecast, 2011-2018 34Table 14: CSF Management, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 34Table 15: CSF Management, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 36Table 16: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2011 39Table 17: Interventional Neurology, United Kingdom, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011 41Table 18: Interventional Neurology, United Kingdom, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018 43Table 19: Embolic Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 45Table 20: Embolic Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 47Table 21: Navigational Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49Table 22: Navigational Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 51Table 23: Interventional Neurology, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 53Table 24: Interventional Neurology, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 55Table 25: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 56Table 26: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 57Table 27: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 58Table 28: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 59Table 29: Interventional Neurology, United Kingdom, Average Price ($), Historic, 2004-2011 60Table 30: Interventional Neurology, United Kingdom, Average Price ($), Forecast, 2011-2018 60Table 31: Interventional Neurology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 61Table 32: Interventional Neurology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 63Table 33: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2011 66Table 34: Neurological Diagnostic Equipment, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 68Table 35: Neurological Diagnostic Equipment, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 70Table 36: Neurological Diagnostic Equipment, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 72Table 37: Neurological Diagnostic Equipment, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 74Table 38: Neurological Diagnostic Equipment, United Kingdom, Average Price ($), Historic, 2004-2011 75Table 39: Neurological Diagnostic Equipment, United Kingdom, Average Price ($), Forecast, 2011-2018 75Table 40: Neurological Diagnostic Equipment, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 76Table 41: Neurological Diagnostic Equipment, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 78Table 42: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2011 81Table 43: Neurostimulation Devices, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 83Table 44: Neurostimulation Devices, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 85Table 45: Neurostimulation Devices, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 87Table 46: Neurostimulation Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 89Table 47: Neurostimulation Devices, United Kingdom, Average Price ($), Historic, 2004-2011 90Table 48: Neurostimulation Devices, United Kingdom, Average Price ($), Forecast, 2011-2018 90Table 49: Neurostimulation Devices, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 91Table 50: Neurostimulation Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 92Table 51: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2011 95Table 52: Neurosurgical Products, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 97Table 53: Neurosurgical Products, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 99Table 54: Neurosurgical Products, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 100Table 55: Neurosurgical Products, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 101Table 56: Neurosurgical Products, United Kingdom, Average Price ($), Historic, 2004-2011 102Table 57: Neurosurgical Products, United Kingdom, Average Price ($), Forecast, 2011-2018 102Table 58: Neurosurgical Products, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 102Table 59: Neurosurgical Products, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 103Table 60: Radiosurgery Market, United Kingdom, Segment Contribution (%), 2011 106Table 61: Radiosurgery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 108Table 62: Radiosurgery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 109Table 63: Radiosurgery, United Kingdom, Average Price ($), Historic, 2004-2011 110Table 64: Radiosurgery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 110Table 65: Radiosurgery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 111Table 66: Neurology Devices Market Pipeline Products 124Table 67: GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 130

Read this article:
United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment ...

China Neurology Devices Market Outlook to 2018 – Interventional Neurology, Neurological Diagnostic Equipment …

Posted on by

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Othershttp://www.reportlinker.com/p0862105/China-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData's new report, "China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the China Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the six market categories. - Global corporate-level profiles of key companies operating within the China Neurology Devices market. - Key players covered include Medtronic, Inc., Accuray Incorporated, DePuy, Inc., B. Braun Melsungen AG, CareFusion Corporation, St. Jude Medical, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the China Neurology Devices competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.

1 Table of Contents

The rest is here:
China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment ...

India Neurology Devices Market Outlook to 2018 – Interventional Neurology, Neurological Diagnostic Equipment …

Posted on by

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0862104/India-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

India Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the six market categories.- Global corporate-level profiles of key companies operating within the India Neurology Devices market. - Key players covered include Terumo Corporation, Medtronic, Inc., DePuy, Inc., CareFusion Corporation, Stryker Corporation, Covidien plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the India Neurology Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.1 Table of Contents1 Table of Contents 21.1 List of Tables 71.2 List of Figures 92 Introduction 112.1 What Is This Report About? 113 Neurology Devices In India 123.1 Neurology Devices, Market Segmentation 123.2 Neurology Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 133.3 Neurology Devices Market, India, Revenue Mix ($m), 2011 153.4 Neurology Devices Market, India, Category Contribution (%), 2011 163.5 Neurology Devices, India, Company Share (2010-2011) 234 CSF Management In India 254.1 CSF Management, Market Segmentation 254.2 CSF Management Market, India, Revenue Mix ($m), 2011 264.3 CSF Management Market, India, Segment Contribution (%), 2011 274.4 CSF Management Overall Revenue, (2004-2018) 284.5 CSF Management Overall Volume (2004-2018) 324.6 CSF Management Average Price (2004-2018) 344.7 CSF Management Distribution Share (2010-2011) 354.8 CSF Management, India, Company Share (2010-2011) 365 Interventional Neurology In India 385.1 Interventional Neurology, Market.Segmentation 385.2 Interventional Neurology Market, India, Revenue Mix ($m), 2011 395.3 Interventional Neurology Market, India, Segment Contribution (%), 2011 405.4 Interventional Neurology Overall Revenue, (2004-2018) 415.4.1 Embolic Systems, Revenue (2004-2018) 455.4.2 Navigational Systems, Revenue (2004-2018) 495.5 Interventional Neurology Overall Volume (2004-2018) 535.5.1 Embolic Systems, Volume (2004-2018) 575.5.2 Navigational Systems, Volume (2004-2018) 595.6 Interventional Neurology Average Price (2004-2018) 615.7 Interventional Neurology Distribution Share (2010-2011) 625.8 Interventional Neurology, India, Company Share (2010-2011) 636 Neurological Diagnostic Equipment In India 656.1 Neurological Diagnostic Equipment, Market.Segmentation 656.2 Neurological Diagnostic Equipment Market, India, Revenue Mix ($m), 2011 666.3 Neurological Diagnostic Equipment Market, India, Segment Contribution (%), 2011 676.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018) 686.5 Neurological Diagnostic Equipment Overall Volume (2004-2018) 726.6 Neurological Diagnostic Equipment Average Price (2004-2018) 766.7 Neurological Diagnostic Equipment Distribution Share (2010-2011) 776.8 Neurological Diagnostic Equipment, India, Company Share (2010-2011) 787 Neurostimulation Devices In India 807.1 Neurostimulation Devices, Market Segmentation 807.2 Neurostimulation Devices Market, India, Revenue Mix ($m), 2011 817.3 Neurostimulation Devices Market, India, Segment Contribution (%), 2011 827.4 Neurostimulation Devices Overall Revenue, (2004-2018) 837.5 Neurostimulation Devices Overall Volume (2004-2018) 877.6 Neurostimulation Devices Average Price (2004-2018) 917.7 Neurostimulation Devices Distribution Share (2010-2011) 927.8 Neurostimulation Devices, India, Company Share (2010-2011) 938 Neurosurgical Products In India 958.1 Neurosurgical Products, Market Segmentation 958.2 Neurosurgical Products Market, India, Revenue Mix ($m), 2011 968.3 Neurosurgical Products Market, India, Segment Contribution (%), 2011 978.4 Neurosurgical Products Overall Revenue, (2004-2018) 988.5 Neurosurgical Products Overall Volume (2004-2018) 1028.6 Neurosurgical Products Average Price (2004-2018) 1048.7 Neurosurgical Products Distribution Share (2010-2011) 1058.8 Neurosurgical Products, India, Company Share (2010-2011) 1069 Radiosurgery In India 1089.1 Radiosurgery, Market Segmentation 1089.2 Radiosurgery Overall Revenue, (2004-2011) 1099.3 Radiosurgery Overall Volume (2004-2011) 1109.4 Radiosurgery Average Price (2004-2011) 1119.5 Radiosurgery Distribution Share (2010-2011) 1119.6 Radiosurgery, India, Company Share (2010-2011) 11110 Overview of Key Companies in India Neurology Devices Market 11210.1 Terumo Corporation 11210.1.1 Company Overview 11210.1.2 Share in the India Neurology Devices Market 11210.2 Medtronic, Inc. 11310.2.1 Company Overview 11310.2.2 Share in the India Neurology Devices Market 11310.3 DePuy, Inc. 11410.3.1 Company Overview 11410.3.2 Share in the India Neurology Devices Market 11410.4 CareFusion Corporation 11510.4.1 Company Overview 11510.4.2 Share in the India Neurology Devices Market 11510.5 Stryker Corporation 11610.5.1 Company Overview 11610.5.2 Share in the India Neurology Devices Market 11610.6 Covidien plc 11710.6.1 Company Overview 11710.6.2 Share in the India Neurology Devices Market 11710.7 Elekta AB 11810.7.1 Company Overview 11810.8 B. Braun Melsungen AG 11810.8.1 Company Overview 11810.9 Sophysa S.A. 11910.9.1 Company Overview 11910.10 Integra LifeSciences Holdings Corporation 11910.10.1 Company Overview 11910.11 Natus Medical Incorporated 12010.11.1 Company Overview 12010.12 St. Jude Medical, Inc. 12010.12.1 Company Overview 12010.13 Nihon Kohden Corporation 12110.13.1 Company Overview 12110.14 Christoph Miethke GmbH & Co. KG 12110.14.1 Company Overview 12110.15 KARL STORZ GmbH & Co. KG 12110.15.1 Company Overview 12110.16 Cadwell Laboratories, Inc. 12210.16.1 Company Overview 12210.17 Boston Scientific Corporation 12210.17.1 Company Overview 12210.18 Cyberonics, Inc. 12210.18.1 Company Overview 12210.19 G. Surgiwear Limited 12310.19.1 Company Overview 12311 Neurology Devices Market Pipeline Products 12412 Appendix 12912.1 Definitions of Markets Covered in the Report 13012.1.1 Neurology Devices 13012.2 Research Methodology 13412.3 Secondary Research 13412.4 Primary Research 13412.5 Models 13512.6 Forecasts 13512.7 Expert Panels 13612.8 GlobalData Consulting 13612.9 Currency Conversion 13612.10 Contact Us 13612.11 Disclaimer 136

List of Tables

Table 1: Neurology Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 14Table 2: Neurology Devices Market, India, Category Contribution (%), 2011 16Table 3: Neurology Devices, India, Cross-Category Analysis, 2004-2018 18Table 4: Neurology Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20Table 5: Neurology Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22Table 6: Neurology Devices, India, Company Share by Revenue ($m), USD Constant, 2010-2011 24Table 7: CSF Management Market, India, Segment Contribution (%), 2011 27Table 8: CSF Management, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 29Table 9: CSF Management, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 31Table 10: CSF Management, India, Volume (Units) by Segment, Historic, 2004-2011 32Table 11: CSF Management, India, Volume (Units) by Segment, Forecast, 2011-2018 33Table 12: CSF Management, India, Average Price ($), Historic, 2004-2011 34Table 13: CSF Management, India, Average Price ($), Forecast, 2011-2018 34Table 14: CSF Management, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35Table 15: CSF Management, India, Company Share by Revenue ($m), USD Constant, 2010-2011 37Table 16: Interventional Neurology Market, India, Segment Contribution (%), 2011 40Table 17: Interventional Neurology, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 42Table 18: Interventional Neurology, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 44Table 19: Embolic Systems, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 46Table 20: Embolic Systems, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 48Table 21: Navigational Systems, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 50Table 22: Navigational Systems, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52Table 23: Interventional Neurology, India, Volume (Units) by Segment, Historic, 2004-2011 54Table 24: Interventional Neurology, India, Volume (Units) by Segment, Forecast, 2011-2018 56Table 25: Embolic Systems, India, Volume (Units) by Sub-Segment, Historic, 2004-2011 57Table 26: Embolic Systems, India, Volume (Units) by Sub-Segment, Forecast, 2011-2018 58Table 27: Navigational Systems, India, Volume (Units) by Sub-Segment, Historic, 2004-2011 59Table 28: Navigational Systems, India, Volume (Units) by Sub-Segment, Forecast, 2011-2018 60Table 29: Interventional Neurology, India, Average Price ($), Historic, 2004-2011 61Table 30: Interventional Neurology, India, Average Price ($), Forecast, 2011-2018 61Table 31: Interventional Neurology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 62Table 32: Interventional Neurology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 64Table 33: Neurological Diagnostic Equipment Market, India, Segment Contribution (%), 2011 67Table 34: Neurological Diagnostic Equipment, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 69Table 35: Neurological Diagnostic Equipment, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 71Table 36: Neurological Diagnostic Equipment, India, Volume (Units) by Segment, Historic, 2004-2011 73Table 37: Neurological Diagnostic Equipment, India, Volume (Units) by Segment, Forecast, 2011-2018 75Table 38: Neurological Diagnostic Equipment, India, Average Price ($), Historic, 2004-2011 76Table 39: Neurological Diagnostic Equipment, India, Average Price ($), Forecast, 2011-2018 76Table 40: Neurological Diagnostic Equipment, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 77Table 41: Neurological Diagnostic Equipment, India, Company Share by Revenue ($m), USD Constant, 2010-2011 79Table 42: Neurostimulation Devices Market, India, Segment Contribution (%), 2011 82Table 43: Neurostimulation Devices, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 84Table 44: Neurostimulation Devices, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 86Table 45: Neurostimulation Devices, India, Volume (Units) by Segment, Historic, 2004-2011 88Table 46: Neurostimulation Devices, India, Volume (Units) by Segment, Forecast, 2011-2018 90Table 47: Neurostimulation Devices, India, Average Price ($), Historic, 2004-2011 91Table 48: Neurostimulation Devices, India, Average Price ($), Forecast, 2011-2018 91Table 49: Neurostimulation Devices, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 92Table 50: Neurostimulation Devices, India, Company Share by Revenue ($m), USD Constant, 2010-2011 94Table 51: Neurosurgical Products Market, India, Segment Contribution (%), 2011 97Table 52: Neurosurgical Products, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 99Table 53: Neurosurgical Products, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 101Table 54: Neurosurgical Products, India, Volume (Units) by Segment, Historic, 2004-2011 102Table 55: Neurosurgical Products, India, Volume (Units) by Segment, Forecast, 2011-2018 103Table 56: Neurosurgical Products, India, Average Price ($), Historic, 2004-2011 104Table 57: Neurosurgical Products, India, Average Price ($), Forecast, 2011-2018 104Table 58: Neurosurgical Products, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 105Table 59: Neurosurgical Products, India, Company Share by Revenue ($m), USD Constant, 2010-2011 107Table 60: Radiosurgery, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 109Table 61: Radiosurgery, India, Volume (Units) by Segment, Historic, 2004-2011 110Table 62: Radiosurgery, India, Average Price ($), Historic, 2004-2011 111Table 63: Radiosurgery, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 111Table 64: Radiosurgery, India, Company Share by Revenue ($m), USD Constant, 2010-2011 111Table 65: Neurology Devices Market Pipeline Products 124

Excerpt from:
India Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment ...

United States Neurology Devices Market Outlook to 2018 – Interventional Neurology, Neurological Diagnostic Equipment …

Posted on by

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

http://www.reportlinker.com/p0862101/United-States-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData's new report, "United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the United States Neurology Devicesmarket.

The rest is here:
United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment ...

Industrial Nanotech, Inc. Announces Expansion to India with Corporate Sales Office

Posted on by

NAPLES, Fla.--(BUSINESS WIRE)--

Industrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanotechnology based energy saving and sustainable solutions announced today that the Company is opening a Corporate Sales Office in India with the next 4-6 weeks. Industrial Nanotech, Inc. has seen significantly increased demand in India for their Nansulate energy saving and protective coatings from OEM manufacturers as well as end manufacturing users to reduce energy costs. The company plans to establish an office first in Southern India, in or near Bangalore, with expansion to Northern India and Western India in the near future.

India has become an increasingly important country as their manufacturing sectors and economy as a whole continue to have a healthy growth rate, stated Francesca Crolley, VP of Business Development for Industrial Nanotech, Inc. We began a strategy this year focused on boosting our marketing and brand presence in India as an energy saving solution and it has returned significant results. These include multiple inquiries from manufacturers that want to use Nansulate coatings for insulation of their equipment for energy savings and surface temperature reduction, as well as a meeting with a leading OEM manufacturer of process cooling systems with 14 locations throughout India, and an international client base, that is interested in incorporating our technology into the process cooling systems they manufacture and sell. We have seen our marketing, which was focused on commercial and industrial, bring in sales and inquiries from multiple markets and at such a response level that it was obvious to us that setting up an Industrial Nanotech, Inc. office in India, staffed by a sales and technical support team which we hire and train, was the logical next step. The availability of a well educated workforce with an excellent work ethic presents a tremendous opportunity for the Company and will allow us to both accommodate factory visit requests from around the country with our own technical teams, as we do in the US, and the ability to more rapidly service and grow this vital market.

India's economic growth is expected to remain robust in 2012 and 2013, despite likely headwind of double-dip recessions in Europe and the US, according to a United Nations' annual economic report - World Economic Situation and Prospects 2012. The Indian economy is expected to grow between 7.7 per cent and 7.9 per cent this year, as per the report. India is the second most preferred destination for foreign investors, according to the report 'Doing Business in India' by Ernst & Young. The report explores India's key sectors, investment climate, funding scenario, laws and regulations, to aid companies that are doing, or plan to do business in India.

About Nansulate

Nansulate is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.inanotk.com) and (www.nansulate.com). Blog: http://www.nansulate.com/nanoblog, Twitter: http://www.twitter.com/NanoPioneer, Facebook: http://www.facebook.com/Nansulate.

About Industrial Nanotech Inc.

Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Follow this link:
Industrial Nanotech, Inc. Announces Expansion to India with Corporate Sales Office

PNNL honored for nanotechnology to help sailors

Posted on by

A nanotechnology system that will allow sailors on Navy submarines to breathe easy has won Pacific Northwest National Laboratory a national award.

The 2012 Federal Laboratory Consortium Interagency Partnership Award was given to the Department of Energy national lab in Richland.

Researchers created a system that captures carbon dioxide directly from the air within a submarine to improve air quality, while providing a more environmentally friendly removal process.

The technology -- self assembled monolayers on mesoporous supports or SAMMS -- can be used to replace a system relied on for more than half a century by the U.S. Navy and many other countries.

The current system is a bulky, heavy, corrosive and malodorous liquid process that produces a significant amount of organic solvent waste, according to PNNL.

"This is a new application of a technology that was previously developed by PNNL to remove heavy metal contamination from ground and surface waters found at many DOE waste sites," PNNL material scientist Glen Fryxell, one of the key inventors of the SAMMS technology, said in a statement.

The SAMMS materials can absorb large quantities of liquid and airborne contaminants without creating secondary waste and can be disposed of as nonhazardous waste.

The SAMMS technology is based on a new class of hybrid nanoporous materials that can rapidly capture contaminants such as carbon dioxide, mercury or arsenic directly from the atmosphere or liquid environments.

For air rejuvenation systems, SAMMS can provide a controlled release of the carbon dioxide using a gentle application of heat or vacuum, according to PNNL.

"The technology could open doors to other large-scale or small-scale air quality treatments," Fryxell said.

Original post:
PNNL honored for nanotechnology to help sailors

Nanoparticles may pose environmental threat

Posted on by

(ISNS) -- No longer the stuff of science fiction, nanoparticles are becoming more and more common. The extremely tiny objects can do just about everything, from filtering pollution to delivering medicine in the body. However, no one is sure of the effects if they get loose in the environment.

A team of scientists from the National Institute of Standards and Technology and the University of Massachusetts at Amherst thinks there may be something to worry about.

They have not proven the particles are dangerous, but have shown that some nanoparticles can be absorbed into plants and mutate the plant's DNA, and that, they say, is worth a further look.

Nanoparticles are so small that they act as a bridge between the size of atoms and something of tangible substance. The thickness of a human hair is measured in millionths of a meter; nanoparticles, in billionths of a meter.

And now, they are everywhere. Manufacturers put them in clothing such as socks to kill bacteria. They are in a type of house paint that cleans itself in sunlight and in the coating on eyeglasses. Clear sunscreen lotion now on the market contains zinc or titanium nanoparticles. Cars will soon have paint that heals itself from scratches.

Nanoparticles have become so common it is assumed inevitably they will end up in the environment.

To see what would happen to plants exposed to nanoparticles, the researchers took particles of copper oxide and exposed three kinds of plants to them: radishes and two types of rye, the researchers reported in Environmental Science & Technology.

They chose nanoparticles of copper because they are widely used for coloring glass, in ceramics, as a polish and in the manufacturing of rayon. They also are used in the electronics industry to manufacture semiconductors, said Bryant Nelson of the National Institute of Standards and Technology.

The research team also used particles of copper oxide larger than nano-size as a comparison as well as regular copper ions.

Copper oxide is an oxidizing agent, and some oxidizing agents from metals can cause cancer in humans, a reason for the concern.

Continued here:
Nanoparticles may pose environmental threat

Global Nanobiotechnology Industry

Posted on by

NEW YORK, May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0181059/Global-Nanobiotechnology-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Nanotechn

This report analyzes the worldwide markets for Nanobiotechnology in US$ Million by the following Technology Segments: Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, & Other Nanomaterials), and Nanodevices/Tools. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 117 companies including many key and niche players worldwide such as Aduro BioTech, Arrowhead Research Corporation, Calando Pharmaceuticals, Inc., Agilent Technologies Inc., Asklepios BioPharmaceutical Inc., Biosante Phosphate Pharmaceuticals, Inc., Celgene Corporation, Elan Pharmaceuticals, Elitech Group, Flamel Technologies, Inc., Gilead Sciences Inc., Life Technologies Corporation, NanoBio Corporation, Nanogen, Inc., Nanophase Technologies Corporation, pSivida Ltd., Sigma Aldrich Company, Starpharma Holdings Ltd., Dendritic Nanotechnologies, Inc., SkyePharma Pharmaceuticals, Unidym, Inc., and Zyvex Instruments LLC. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-3Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-31. Nanomaterials I-4Solid Inorganic Nanoparticles I-4Nanocomposites I-4Nanostructured Materials and Membranes I-4Nanotubes and Fullerenes I-4Other Nanomaterials I-4Nanoshells I-4Nanohorns I-5Nanocapsules I-52. Nanodevices/Tools I-5II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1

A Curtain Raiser II-1

Nanobiotechnology - The Next Big Thing II-2

Nanotechnology & Biology Tie the Knot: "Two to Tango" II-4

Where Conventional Molecular Science Falls Short Nanobio

Steps In II-4

Excerpt from:
Global Nanobiotechnology Industry